Addisonian crisis is an acute and life-threatening complication of adrenal failure. A 44-years old female case presented with Addisonian crisis following a two-week anti tuberculosis treatment because of tuberculosis lymphadenitis. Panhypopituitarism was detected at investigations for aetiology. Acceleration of cortisol metabolism by rifampicin treatment was blamed for the Addisonian crisis.
Follicle stimulating hormone (FSH), luteinising hormone (LH) and oestradiol (E2) were compatible with hypogonadotropic hypogonadism. FSH: 5 (21.7-153) mIU/mL, LH: 1.6 (11.3-50) mIU/mL, E2: 10 (12.5-166) pg/mL, prolactin: 20 (2.7-26) ng/mL without response after insulin hypoglycaemia. Hypogonadotropic hypogonadism and secondary adrenal failure were detected.
Steroid (methylprednisolone) and thyroid hormone replacements were added to the anti-tuberculosis treatment. The patient recovered and electrolytes were normalised during follow-up. Hypophysis magnetic resonance imaging (MRI) to determine the aetiology of pituitary failure revealed cerebrospinal fluid (CSF) herniation at the location of adenohypophysis and parenchyma of adenohypophysis had a linear pattern (Figure 2 ).
After a week of aetiological research, anti-tuberculosis treatment including rifampicin (10 mg/kg/day) with oral prednisolone (5 mg) and thyroid hormone (100 mg) was started. Liver function tests were normal at the time of Addisonian crisis, so that rifampicin was added to the anti-tuberculosis treatment. When rifampicin was re-administered, no symptoms of adrenal crisis were thereafter again observed. During the antituberculosis treatment, corticosteroid replacement therapy was continued. Radiological and clinical improvement was observed in the patient after two months and anti-tuberculosis treatment was continued. including INH and RIF. There was no cervical lymphadenopathy upon physical examination. Also, weight gain and a decrease in ESR were seen. Antituberculosis treatment was completed at sixth months due to resolution of symptoms and there has been no follow-up for the last six months.
dIscUssIon Hypopituitarism (failure of the pituitary gland) is a clinical syndrome due to the insufficient production and release of one or more pituitary hormones. Deficiency of all pituitary hormones is known as panhypopituitarism. The mortality rate of patients with hypopituitarism is 1.2 to 2.2 times that of normal subjects. Hypopituitarism generally progresses slowly except in conditions like hypophysis apoplexy and Sheehan's syndrome. Subclinical forms may easily be overlooked. Diagnosis is made with the detection of low hormone levels both in the pituitary gland and in target organs [2] .
Patients with secondary adrenal failure due to hypopituitarism have nonspecific symptoms such as chronic fatigue, malaise, anorexia, and weight loss. Nausea, vomiting, and abdominal pain may also be observed. Blood pressure is low in many patients but only postural hypotension may be detected in some.
Our patient had nonspecific complaints such as malaise and fatigue, which were thought to be associated with tuberculosis. However, nausea, vomiting, and hypotension developed after anti-tuberculosis treatment and laboratory evaluation revealed hyponatremia. Hormone levels were seen because of refractory hyponatremia and examination for anterior pituitary abnormality detected panhypopituitarism. In pituitary MRI, adenohypophysis was in a linear pattern.
Rifampicin is included in the standard anti-tuberculosis treatment regime. Rifampicin is known to induce liver enzymes and increase cortisol metabolism due to increased cytochrome p450 activity [1, 3] . Our patient had secondary adrenal failure due to undiagnosed panhypopituitarism when anti-tuberculosis treatment was initiated, which presented as Addisonian crisis. In the literature, there are many similar reports of Addisonian crisis and Addison's disease induced by rifampicin treatment [4, 5] .
Addisonian crisis is the acute and life threatening complication of adrenal failure. It may develop in a patient with previous chronic adrenal failure or may be the presenting sign in a previously undiagnosed patient. Triggering factors may be infections, surgical procedures, cessation of glucocorticoid treatment, and not increasing glucocorticoid dose in the presence of stress factors. We believe that the factor that triggered the Addisonian crisis in our case was rifampicin treatment (which increases cortisol clearance) in the presence of secondary adrenal failure due to undiagnosed pituitary insufficiency. Tuberculosis may affect many of the endocrine glands, including the hypothalamus, pituitary and thyroid, but the most commonly involved endocrine organ is the adrenal gland [5, 6] . However, in this case, tuberculosis was not disseminated and adenohypophysis was found in a linear pattern following pituitary MRI.
Our patient was followed in the intensive care unit after emergency room admission. Fluids and electrolytes were regulated and glucocorticoid treatment was initiated after samples had been taken. Because hormonal assessments were consistent with panhypopituitarism, levothyroxine was added to the treatment regime after glucocorticoid replacement. She recovered and nausea and vomiting disappeared at follow-up. Vital signs and serum sodium concentration were normalised. Maintenance treatment was planned and anti-tuberculosis treatment was continued. She was informed of the adrenal failure and its symptoms, and was recommended to carry an information card with her; follow-up visits were arranged, and the patient was discharged. We hope that our experience might help fellow physicians in their future diagnoses.
